Flavia Catalina Corciova1, Catalina Arsenescu-Georgescu. 1. "Gr. T. Popa" University of Medicine and Pharmacy, Iasi, Romania ; "Prof. Dr. George Georgescu" Institute of Cardiovascular Diseases, Iasi, Romania.
Abstract
BACKGROUND AND OBJECTIVES: Pulmonary hypertension is a hemodynamic and pathophysiological condition defined as an increase in mean pulmonary pressure more than or equal to 25 mm Hg. Evaluation of pulmonary hypertension severity and prognosis plays a central role in the management of these patients, between diagnosis and therapeutic decision making. The aim of our study was to identify the adverse prognostic factors in patients with pulmonary hypertension and their impact on mortality, quality of life, need for hospitalization and complications during hospitalization. MATERIAL AND METHODS: We performed a prospective study that included 553 patients diagnosed with pulmonary hypertension in the Institute of Cardiovascular Diseases of Iasi between 1st November 2008 and 1st July 2011. We analyzed a series of demographic and clinical data, echocardiographic and hemodynamic parameters, which correlated with mortality, WHO functional class, complications and need for hospitalization. OUTCOMES: We identified as main negative prognostic factors: WHO functional class III and IV, the pulmonary artery systolic pressure value, right chambers dilation, TAPSE, pericardial effusion, cardiac index and right atrial pressure. CONCLUSIONS: Pulmonary hypertension, despite the development of treatment methods, remains a serious disease, with progressive and inexorable evolution, but the prognosis of patients with pulmonary hypertension is very variable, depending on the etiology, functional class, clinical, echocardiographic and hemodynamic parameters.
BACKGROUND AND OBJECTIVES:Pulmonary hypertension is a hemodynamic and pathophysiological condition defined as an increase in mean pulmonary pressure more than or equal to 25 mm Hg. Evaluation of pulmonary hypertension severity and prognosis plays a central role in the management of these patients, between diagnosis and therapeutic decision making. The aim of our study was to identify the adverse prognostic factors in patients with pulmonary hypertension and their impact on mortality, quality of life, need for hospitalization and complications during hospitalization. MATERIAL AND METHODS: We performed a prospective study that included 553 patients diagnosed with pulmonary hypertension in the Institute of Cardiovascular Diseases of Iasi between 1st November 2008 and 1st July 2011. We analyzed a series of demographic and clinical data, echocardiographic and hemodynamic parameters, which correlated with mortality, WHO functional class, complications and need for hospitalization. OUTCOMES: We identified as main negative prognostic factors: WHO functional class III and IV, the pulmonary artery systolic pressure value, right chambers dilation, TAPSE, pericardial effusion, cardiac index and right atrial pressure. CONCLUSIONS:Pulmonary hypertension, despite the development of treatment methods, remains a serious disease, with progressive and inexorable evolution, but the prognosis of patients with pulmonary hypertension is very variable, depending on the etiology, functional class, clinical, echocardiographic and hemodynamic parameters.
Entities:
Keywords:
echocardiography; mortality; prognosis; pulmonary hypertension; right heart catheterization
Authors: Vallerie V McLaughlin; Kenneth W Presberg; Ramona L Doyle; Steven H Abman; Douglas C McCrory; Terry Fortin; Gregory Ahearn Journal: Chest Date: 2004-07 Impact factor: 9.410
Authors: Paul R Forfia; Micah R Fisher; Stephen C Mathai; Traci Housten-Harris; Anna R Hemnes; Barry A Borlaug; Elzbieta Chamera; Mary C Corretti; Hunter C Champion; Theodore P Abraham; Reda E Girgis; Paul M Hassoun Journal: Am J Respir Crit Care Med Date: 2006-08-03 Impact factor: 21.405
Authors: Raymond L Benza; Dave P Miller; Mardi Gomberg-Maitland; Robert P Frantz; Aimee J Foreman; Christopher S Coffey; Adaani Frost; Robyn J Barst; David B Badesch; C Gregory Elliott; Theodore G Liou; Michael D McGoon Journal: Circulation Date: 2010-06-28 Impact factor: 29.690
Authors: Daniel G Blanchard; Philip J Malouf; Swaminatha V Gurudevan; William R Auger; Michael M Madani; Patricia Thistlethwaite; Thomas J Waltman; Lori B Daniels; Ajit B Raisinghani; Anthony N DeMaria Journal: JACC Cardiovasc Imaging Date: 2009-02
Authors: Nazzareno Galiè; Marius M Hoeper; Marc Humbert; Adam Torbicki; Jean-Luc Vachiery; Joan Albert Barbera; Maurice Beghetti; Paul Corris; Sean Gaine; J Simon Gibbs; Miguel Angel Gomez-Sanchez; Guillaume Jondeau; Walter Klepetko; Christian Opitz; Andrew Peacock; Lewis Rubin; Michael Zellweger; Gerald Simonneau Journal: Eur Heart J Date: 2009-08-27 Impact factor: 29.983
Authors: Karl P Kuhn; Daniel W Byrne; Patrick G Arbogast; Thomas P Doyle; James E Loyd; Ivan M Robbins Journal: Am J Respir Crit Care Med Date: 2002-11-21 Impact factor: 21.405
Authors: Salim Hayek; Daniel B Sims; David W Markham; Javed Butler; Andreas P Kalogeropoulos Journal: Circ Cardiovasc Imaging Date: 2014-03 Impact factor: 7.792
Authors: Karen S W Chia; Steven G Faux; Peter K K Wong; Cameron Holloway; Hassan Assareh; Craig S McLachlan; Eugene Kotlyar Journal: BMJ Open Date: 2017-02-06 Impact factor: 2.692
Authors: Jiandong Zhou; Oscar Hou In Chou; Ka Hei Gabriel Wong; Sharen Lee; Keith Sai Kit Leung; Tong Liu; Bernard Man Yung Cheung; Ian Chi Kei Wong; Gary Tse; Qingpeng Zhang Journal: Front Cardiovasc Med Date: 2022-07-08
Authors: Benjamin Smith; Michael V Genuardi; Agnes Koczo; Richard H Zou; Floyd W Thoma; Adam Handen; Ethan Craig; Caroline M Hogan; Timothy Girard; Andrew D Althouse; Stephen Y Chan Journal: Pulm Circ Date: 2018-07-03 Impact factor: 3.017